CareTrust REIT CTRE
United StatesReal Estate · REIT - Healthcare FacilitiesUSD
44.77 USD (+25.0%)
13 analysts
Trading 2120.30 €Open account ↗
Lightyear0.90 €Open account ↗
N260.90 €Open account ↗
XTB1.00 €★ featured · affiliateOpen account ↗Trading 2120.30 €Open account ↗Lightyear0.90 €Open account ↗XTB1.00 €★ featured · affiliateOpen account ↗200.00 € order · cheapest cheapest available in your country iCompare all 22 brokers →What does it do?
CareTrust REIT, Inc. is a real estate investment trust (REIT) that owns, acquires, and leases healthcare properties, primarily skilled nursing facilities and assisted living facilities, to healthcare operators.
Key points
from its scores- ✓Very solid balance sheet8.2
- ✓Strong growth8.2
- ✓Good share-price trend7.4
- ✕Demanding valuation3.5
- ✕Little competitive advantage4.4
AI analysis
bottom line, main risk, context and newsSolid financial health and revenue growth are offset by a demanding valuation in a rising rate environment and negative free cash flow generation.
CareTrust REIT shows solid financial health (8.52) with moderate leverage (Net Debt/EBITDA of 2.39), but its valuation (3.97) is pressured by the rising interest rate environment, which affects long-duration assets. Revenue growth is strong (43.5%), although free cash flow conversion is negative (-16.56%), a weakness to watch.
The main risk is the sensitivity of its real estate asset valuations and financing costs to a rising interest rate environment, which could compress multiples and refinancing margins.
Context and risks
The rise in long-term US interest rates (10-year Treasury at 5.28%) pressures the valuation of real estate assets and makes debt refinancing more expensive, a relevant factor for a REIT with Net Debt/EBITDA of 2.39. The position in the 28th percentile of the 52-week range suggests the market is already discounting part of this risk.
Is CareTrust REIT stock cheap or expensive?
at the analysis dateOn P/E and Price / book, it trades 18% above the Real Estate median on average.
| Multiple | Company | Sector | Difference |
|---|---|---|---|
| P/E | 22.4 | 21.6 | +4% |
| EV / EBITDA | 19.9 | 18.5 | +8% |
| Price / book | 1.9 | 1.4 | +32% |
| Price / sales | 14.8 | 6.3 | +135% |
Sector: median of the 100 Real Estate companies analysed. In bold, the multiples used for the comparison.
Valuation score: 3.5 out of 10 (median for Real Estate: 4.9).
Average analyst target: 44.77 USD, +25.0% versus the price.
A premium can be justified if the company is of higher quality or grows faster than its sector: Quality / Moat 4.4 (sector 5.2), Growth 8.2 (sector 5.7).
Classic formulas with standard assumptions (10.0% growth, 8-9% discount rate). Indicative only: they change a lot with the assumptions and are not a recommendation.
Work out its fair value yourself →How much would you have made investing every month? →
Comparing it with its sector does not say whether it is a good buy: this is not investment advice.
Score by category
0 to 10 · hover overtap each one to see what it measuresKey metrics
at the analysis date · compared with the Real Estate medianValuation
- P/E
- 22.4
- Forward P/E
- 20.2
- EV / EBITDA
- 19.9
- Price / book
- 1.9
- Price / sales
- 14.8
- PEG
- 2.35
- Market cap
- 8.5B USD
- Enterprise value
- 9.6B USD
Profitability
- ROE
- 9.1%
- ROA
- 4.4%
- ROIC (approx.)
- 6.5%
- Gross margin
- 96.4%
- Operating margin
- 64.9%
- Net margin
- 62.2%
- Free cash flow
- −80.3M USD
- FCF yield
- −0.9%
- Cash conversion
- −17%
Solvency
- Total debt
- 1.2B USD
- Net debt
- 1.2B USD
- Cash
- 47.6M USD
- EBITDA
- 484.9M USD
- Net debt / EBITDA
- 2.39
- Debt / equity
- 26.70
- Current ratio
- 3.30
- Quick ratio
- 2.95
Growth
- Revenue growth
- +43.5%
- Earnings growth
- +8.6%
- EPS (TTM)
- 1.60 USD
- EPS (forward)
- 1.77 USD
Dividend
- Dividend yield
- 4.4%
- Payout
- 90.6%
Risk and market
- Beta
- 0.77
- Analyst consensus
- Strong buy (13)
- Target price
- 44.77 USD
- 52-week range
- 32.79 – 43.62
Recent news
All CTRE news →Compare it with its sector
All 100 in Real Estate →Frequently asked questions about CareTrust REIT
Is CareTrust REIT stock cheap or expensive?
On P/E and Price / book, it trades 18% above the Real Estate median on average. Valuation score: 3.5 out of 10 (median for Real Estate: 4.9). Average analyst target: 44.77 USD, +25.0% versus the price. This is not investment advice.
What score does CareTrust REIT get on MeridIAn Screener?
It scores 6.1 out of 10, rank 885 of 2,130 (better than 55% of the companies analysed). Its strongest category is Financial health (8.2) and its weakest, Valuation (3.5). Analysis of 08/10/2026.
What is CareTrust REIT's P/E ratio?
Its P/E is 22.4: the share price equals 22.4 times earnings per share over the last 12 months. The Real Estate median is 21.6. Based on the earnings analysts expect, the forward P/E is 20.2.
How much is CareTrust REIT worth on the stock market?
Its market capitalisation is 8.5B USD.
Does CareTrust REIT pay a dividend?
Yes: its dividend yield is 4.36% and it pays out 91% of its earnings.
How has CareTrust REIT stock performed over the last year?
It has risen 12.3% over the last year, excluding dividends. Over the last 52 weeks it has traded between 32.79 and 43.62 USD. Past performance does not guarantee future results.
What do analysts think of CareTrust REIT?
13 analysts cover it; their average recommendation is “Strong buy” and their average target is 44.77 USD (+25.0% versus the price). It is an estimate, not market data.